Bio-Techne Corp (NASDAQ:TECH)
| 257.25 Delayed Data As of May 27 |  -3.38 / -1.30%Today’s Change | 155.17 Today|||52-Week Range 282.52 | +17.19% Year-to-Date |
Latest TECH News | Press Releases
No recent news for Bio-Techne Corp.
Today’s Trading
| Previous close | 260.65 |
| Today’s open | 257.74 |
| Day’s range | 245.46 - 258.24 |
| Volume | 291,715 |
| Average volume (3 months) | 263,110 |
| Market cap | $9.9B |
Data as of 4:00pm ET, 05/27/2020
Growth & Valuation
| Earnings growth (last year) | -24.48% |
| Earnings growth (this year) | -3.37% |
| Earnings growth (next 5 years) | +8.50% |
| Revenue growth (last year) | +11.04% |
| P/E ratio | 54.2 |
| Price/Sales | 11.36 |
| Price/Book | 8.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NBIXNeurocrine Bioscienc... | +0.22 | +0.19% |
| IMMUImmunomedics Inc | +0.07 | +0.21% |
| EXASExact Sciences Corp | +1.30 | +1.61% |
| ALLOAllogene Therapeutic... | -0.36 | -0.73% |
Data as of 4:58pm ET, 05/27/2020
Financials
| Next reporting date | August 11, 2020 |
| EPS forecast (this quarter) | $0.75 |
| Annual revenue (last year) | $714.0M |
| Annual profit (last year) | $96.0M |
| Net profit margin | 13.44% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Minneapolis, Minnesota |
Forecasts
